We are monitoring the impact of COVID-19 & Recession alarm on Europe Digital Therapeutics Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Digital Therapeutics Market Size, Share, Trends and Growth Analysis Report – Segmented By Product, Sales Channel, Application and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 11328
Pages: 110

Europe Digital Therapeutics Market Size (2022 to 2027)

The Europe Digital Therapeutics Market size was worth USD 612 million in 2020. This value is further forecasted to be growing at a CAGR of 21.4% between 2022 to 2027.

The growing smartphone and internet usage among people and the rising usage of other smart devices in European regions are significant drivers for the digital therapeutics market. Europe spends more than $124 billion a year on the treatment of chronic illness. Digital therapeutics help in diminishing these healthcare costs. Moreover, the increasing prevalence of chronic diseases such as diabetes drives the European Digital Therapeutics Market (DTx). For instance, according to the European Chronic Disease Alliance (ECDA), more than 85% of the deaths were registered in the European Union due to chronic diseases, including cancer, diabetes, chronic respiratory disease, cardiovascular disease, and mental illness. The rise in the prevalence of diabetic patients and patients willing to adapt to different treatment types boosts the market. Increasing government initiatives for preventive healthcare will further increase awareness among people and promote digital therapeutics. The user-friendliness and patient convenience factor of digital therapeutics are also significant advantages. The technological advancements in mobile healthcare are the key to the growth of the European Digital Therapeutics market.

The significant restriction for the European digital therapeutics market is the lack of access to digital therapeutics programs in developing countries. The low awareness among people about these programs' benefits is due to the lack of access to the proper technology is further hindering the growth rate of the European Digital Therapeutics Market. Moreover, cybersecurity poses a significant threat to databases. The hackers may hack the digital platforms and get all the private data related to the patients. Hence, the security and privacy concerns of the patient's medical data hamper the market growth. Further, the unstable payment models and resistance from traditional healthcare providers will affect market growth negatively during the forecast period. These are the factors that are restraining the European digital therapeutics market.

COVID-19 Impact on European digital therapeutics market:

The COVID-19 pandemic had negatively affected the healthcare system in Europe. But the pandemic has positively impacted the global digital therapeutics market and boosted the growth rate. Digital therapeutics help us treat, manage, and monitor the disease at any place without going to hospitals and contacting other people. So even the doctors had started treating their patients using digital applications. In addition, the increase in smartphone usage during the pandemic help the market grow during these challenging times.

The research report European digital therapeutics market has been segmented and sub-segmented into the following categories.

By Product:

  • Software
  • Device
  • Others

By Sales Channel:

  • B2C
    • Patients
    • Caregivers
  • B2B
    • Providers
    • Payers
    • Employers
    • Pharmaceutical Companies
    • Other Buyers

By Application:

  • Preventive Applications
    • Prediabetes
    • Obesity
    • Nutrition
    • Lifestyle Management
    • Other Preventive Applications
  • Treatment/Care-related Applications
    • Diabetes
    • CNS Disorders
    • Chronic Respiratory Disorders
    • Musculoskeletal Disorders
    • Cardiovascular Diseases
    • Smoking Cessation
    • Medication Adherence
    • Gastrointestinal Disorders
    • Substance Use & Addiction Management
    • Rehabilitation & Patient Care
    • Other Treatment/Care-related Applications

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European digital therapeutics market was the second-largest market in 2019 and grow consistently in the near future. The rise in the adoption of smartphones and tablets coupled with healthcare applications in the European region boosts the European Digital Therapeutics Market. For instance, Oxil launched an app in 2017, which is used to tackle mounting cases of obesity, mainly among youth. In addition, some other developers like Azumio provide a fitness buddy mobile app that offers the most prominent exercise database that helps reduce obesity.

At this moment, the German digital therapeutics market is estimated to dominate the European market. Furthermore, fast-track reimbursement policies available in Germany are significantly accelerating the digital therapeutics market in Germany.

The U.K. digital health market is estimated to be another lucrative regional market in Europe. The increase in private funding in developing some new applications is boosting the market. Moreover, the rise in adoption and awareness of Digital Therapeutics is propelling the market growth. Further, the increase in the prevalence of diabetes and chronic diseases boosts the European digital therapeutics market's growth. For instance, in 2018, Diabetes is accounted for the highest share and registered a CAGR of 22.6% during the forecast period.

The Italian digital therapeutics market is predicted to showcase a healthy growth rate during the forecast period.

KEY MARKET PLAYERS:

Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are some of the key companies operating in the European digital therapeutics market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Software
      2. Device
      3. Others
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By Sales Channel
      1. B2C
        1. Patients
        2. Caregivers
      2. B2B
        1. Providers
        2. Payers
        3. Employers
        4. Pharmaceutical Companies
        5. Other Buyers
      3. Y-o-Y Growth Analysis, By Sales Channel
      4. Market Attractiveness Analysis, By Sales Channel
      5. Market Share Analysis, By Sales Channel
    3. By Application
      1. Preventive Applications
        1. Prediabetes
        2. Obesity
        3. Nutrition
        4. Lifestyle Management
        5. Other Preventive Applications
      2. Treatment/Care-related Applications
        1. Diabetes
        2. CNS Disorders
        3. Chronic Respiratory Disorders
        4. Musculoskeletal Disorders
        5. Cardiovascular Diseases
        6. Smoking Cessation
        7. Medication Adherence
        8. Gastrointestinal Disorders
        9. Substance Use & Addiction Management
        10. Rehabilitation & Patient Care
        11. Other Treatment/Care-related Applications
      3. Y-o-Y Growth Analysis, By Application
      4. Market Attractiveness Analysis, By Application
      5. Market Share Analysis, By Application
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. 2Morrow, Inc.,
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pear Therapeutics, Inc.
    3. Fitbit, Inc. (Twine Health, Inc.)
    4. Proteus Digital Health, Inc.
    5. Livongo Health, Inc.
    6. Resmed, Inc. (Propeller Health)
    7. Medtronic Plc.
    8. Voluntis, Inc.
    9. Omada Health, Inc.
    10. Welldoc, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  1. Europe Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  2. Europe Software Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Device Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  6. Europe B2C Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe B2B Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  9. Europe Preventive Application Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Treatment/Care-related Applications Market, By Region, From 2022 - 2027 (USD Million)
  11. U.K. Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  12. U.K. Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  13. U.K. Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  14. Germany Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  15. Germany Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  16. Germany Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  17. France Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  18. France Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  19. France Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  20. Italy Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  21. Italy Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  22. Italy Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  23. Spain Digital therapeutics Market, By Product, From 2022 - 2027 (USD Million)
  24. Spain Digital therapeutics Market, By Sales Channels, From 2022 - 2027 (USD Million)
  25. Spain Digital therapeutics Market, By Application, From 2022 - 2027 (USD Million)
  26. Europe Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  27. Europe Providers Market, By Region, From 2022 - 2027 (USD Million)
  28. Europe Payers Market, By Region, From 2022 - 2027 (USD Million)
  29. Europe Employers Market, By Region, From 2022 - 2027 (USD Million)
  30. Europe Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  31. Europe Other Buyers Market, By Region, From 2022 - 2027 (USD Million)
  32. U.K. Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  33. Germany Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  34. France Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  35. Italy Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  36. Spain Blood Glucose Monitoring Market, By B2B, From 2022 - 2027 (USD Million)
  37. Europe Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  38. Europe Patients Market, By Region, From 2022 - 2027 (USD Million)
  39. Europe Caregivers Market, By Region, From 2022 - 2027 (USD Million)
  40. U.K. Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  41. Germany Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  42. France Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  43. Italy Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  44. Spain Blood Glucose Monitoring Market, By B2C, From 2022 - 2027 (USD Million)
  45. Europe Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  46. Europe Prediabetes Market, By Region, From 2022 - 2027 (USD Million)
  47. Europe Obesity Market, By Region, From 2022 - 2027 (USD Million)
  48. Europe Nutrition Market, By Region, From 2022 - 2027 (USD Million)
  49. Europe Lifestyle Management Market, By Region, From 2022 - 2027 (USD Million)
  50. Europe Other Preventive Applications Market, By Region, From 2022 - 2027 (USD Million)
  51. U.K. Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  52. Germany Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  53. France Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  54. Italy Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  55. Spain Blood Glucose Monitoring Market, By Preventive Applications, From 2022 - 2027 (USD Million)
  56. Europe Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)
  57. Europe Diabates Market, By Region, From 2022 - 2027 (USD Million)
  58. Europe CND disorders Market, By Region, From 2022 - 2027 (USD Million)
  59. Europe Chronic Respiratory Disorders Market, By Region, From 2022 - 2027 (USD Million)
  60. Europe Muscloskeletal Disorders Market, By Region, From 2022 - 2027 (USD Million)
  61. Europe Cardiovascular Diseases Market, By Region, From 2022 - 2027 (USD Million)
  62. Europe Smoking Cessation Market, By Region, From 2022 - 2027 (USD Million)
  63. Europe Medication Adherence Market, By Region, From 2022 - 2027 (USD Million)
  64. Europe Gastrointestinal disorders Market, By Region, From 2022 - 2027 (USD Million)
  65. Europe Substance use & Addiction Management Market, By Region, From 2022 - 2027 (USD Million)
  66. Europe Rehabilitation & Patient Care Market, By Region, From 2022 - 2027 (USD Million)
  67. U.K. Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)
  68. Germany Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)
  69. France Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)
  70. Italy Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)
  71. Spain Blood Glucose Monitoring Market, By Treatment/Care-realted Application, From 2022 - 2027 (USD Million)

 

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample